您的位置: 首页 > 2022年11月 第52卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

家庭药师与药物治疗管理对签约患者用药依从性及不合理用药干预效果

Intervention effects of family pharmacists and medication management on medication compliance and unreasonable medication use of contracted patients

来源期刊: 广州医药 | 79-82 发布时间:2022-11-30 收稿时间:2025/11/13 18:15:00 阅读量:43
作者:
关键词:
慢性病家庭药师药物治疗管理依从性
chronic diseasefamily pharmacistmedication managementcompliance
DOI:
10.3969/j.issn.1000-8535.2022.06.017
收稿时间:
2021-09-06 
修订日期:
 
接收日期:
 
引用总数:
5  
目的 探讨家庭药师与药物治疗管理对签约患者用药依从性及不合理用药干预效果。方法 选取2017年3月—2021年3月我院收治的慢性病患者100例作为前瞻性研究对象,按照随机余数法分为对照组和研究组各50例。其中,对照组实施首次随访调查,收集患者健康信息建立用药档案,末次随访评价。研究组采用收集患者健康信息,建立用药档案,填写调查表,对在用的药物治疗方案进行评价,家庭药师与家庭医生协作共同干预或直接干预,制定具体的解决方案,帮助患者达到治疗目标。比较2组患者干预前后的药物依从性、生活质量及用药情况的变化。结果 干预前,2组患者的药物依从性评分比较无统计学意义(P >0.05),干预后,2组患者药物依从性评分比较随时间增加而改善,而研究组的药物依从性评分显著高于对照组,统计学显示差异有统计学意义(P<0.05)。2组患者的选择合理、给药频率合理、滴定合理、换药合理、联合用药合理均有明显改善且研究组多于对照组,比较差异有统计学意义(P<0.05)。结论 家庭药师及药物治疗管理干预能够有效提高患者用药依从性及生活质量,改善用药情况,对慢性病患者干预具有一定参考价值。
Objective To explore intervention the effect of family pharmacist and medication management on medication compliance and unreasonable drug use in contracted patients. Methods A total of 100 patients with chronic diseases from March 2017 to March 2021 in our hospital were selected as prospective study subjects. According to the random remainder method,they were divided into control group and research group with 50 cases in each group. Among them,the control group was surveyed in the first followed-up,and the health information of patients was collected to establish drug use files,and evaluation was performed in the final follow-up. Family pharmacists and family physicians intervened together or directly to formulate specific solutions to help patients achieve the treatment goals and explain the treatment goals. The changes of medication compliance,quality of life and drug use before and after intervention were compared between the two groups. Results Before the intervention,the medication compliance scores of the two groups were not significantly different (P>0.05).After the intervention,the medication compliance scores of the two groups improved with time,while the medication compliance scores of the research group were significantly higher than the control group,statistics analysis showed that the difference was significant (P<0.05).The reasonable selection,the reasonable frequency,the reasonable titration,the reasonable drug change,and the reasonable combined medication in research group were significantly more than the control group,and the differences were statistically significant (P<0.05).Conclusions Family pharmacist and medication management intervention could effectively improve medication compliance and quality of life of patients,improve drug use,had a certain reference value for chronic disease patients.
1、 张伶俐,张扬,曾力楠,等.美国临床药师的工作职责及定位[J].中国药房,2016,27(34):4753-4756. 张伶俐,张扬,曾力楠,等.美国临床药师的工作职责及定位[J].中国药房,2016,27(34):4753-4756.
2、 SCHWARTZ E J,BSCPHARM J T,BSCPHARM J P,等.世界家庭医生组织(WONCA)研究论文摘要汇编——初级卫生保健中实施标准化药物治疗管理的附加方法[J].中国全科医学,2018,21(1):113. SCHWARTZ E J,BSCPHARM J T,BSCPHARM J P,等.世界家庭医生组织(WONCA)研究论文摘要汇编——初级卫生保健中实施标准化药物治疗管理的附加方法[J].中国全科医学,2018,21(1):113.
3、 吴晓玲,谢奕丹,邱宇翔,等.家庭药师制度的构建与实践探索[J].今日药学,2018,28(5):340-343,348. 吴晓玲,谢奕丹,邱宇翔,等.家庭药师制度的构建与实践探索[J].今日药学,2018,28(5):340-343,348.
4、 何舜娟,高卉.家庭医生团队中药学服务型药师的培养[J].重庆医学,2018,47(12):1694-1695. 何舜娟,高卉.家庭医生团队中药学服务型药师的培养[J].重庆医学,2018,47(12):1694-1695.
5、 KEATING G M.Dexmedetomidine: a review of its use for sedation in the intensive care setting[J].Drugs,2015,75(10):1119-1130. KEATING G M.Dexmedetomidine: a review of its use for sedation in the intensive care setting[J].Drugs,2015,75(10):1119-1130.
6、 KIRKEGAARD H,TACCONE F S,SKRIFVARS M,et al.Postresuscitation care after out-of-hospital cardiac arrest: clinical update and focus on targeted temperature management[J].Anesthesiology,2019,131(1):186-208. KIRKEGAARD H,TACCONE F S,SKRIFVARS M,et al.Postresuscitation care after out-of-hospital cardiac arrest: clinical update and focus on targeted temperature management[J].Anesthesiology,2019,131(1):186-208.
7、 JERATH A,PANCKHURST J,PAROTTO M,et al.Safety and efficacy of volatile anesthetic agents compared with standard intravenous midazolam/propofol sedation in ventilated critical care patients: a Meta-analysis and systematic review of prospective trials[J].Anesth Analg,2017,124(4):1190-1199. JERATH A,PANCKHURST J,PAROTTO M,et al.Safety and efficacy of volatile anesthetic agents compared with standard intravenous midazolam/propofol sedation in ventilated critical care patients: a Meta-analysis and systematic review of prospective trials[J].Anesth Analg,2017,124(4):1190-1199.
8、 DALFINO L,BRIENZA N,BRUNO F.Patient-targeted light sedation in the Intensive Care Unit: are we ready for precision medicine with dexmedetomidine? [J].Minerva Anestesiol, 2018,84(6):661-663. DALFINO L,BRIENZA N,BRUNO F.Patient-targeted light sedation in the Intensive Care Unit: are we ready for precision medicine with dexmedetomidine? [J].Minerva Anestesiol, 2018,84(6):661-663.
9、 高植明,陈煜初,赵玉珊,等.社区药学服务模式探索[J].中国医院用药评价与分析,2016,16(7):982-985. 高植明,陈煜初,赵玉珊,等.社区药学服务模式探索[J].中国医院用药评价与分析,2016,16(7):982-985.
10、 刘治军,王巧黎,李玮,等.2010年中国城镇居民家庭药箱调查结果与药学服务应对分析[J].中国医院用药评价与分析,2011,11(9):853-857. 刘治军,王巧黎,李玮,等.2010年中国城镇居民家庭药箱调查结果与药学服务应对分析[J].中国医院用药评价与分析,2011,11(9):853-857.
11、 唐杨琛,黄毕林,沈干,等.中国基层临床指南现状分析及评价[J].中华高血压杂志,2013,21(1):48-52. 唐杨琛,黄毕林,沈干,等.中国基层临床指南现状分析及评价[J].中华高血压杂志,2013,21(1):48-52.
12、 徐勇勇,孙振球,颜虹.医学统计学(第三版)[M].北京:高等教育出版社,2017:61-65. 徐勇勇,孙振球,颜虹.医学统计学(第三版)[M].北京:高等教育出版社,2017:61-65.
13、 何芳玲,袁意敬,符艳芬,等.临床药师利用智能血压计对社区高血压患者提供药学服务的影响研究[J].实用药物与临床,2019,22(11):1194-1198. 何芳玲,袁意敬,符艳芬,等.临床药师利用智能血压计对社区高血压患者提供药学服务的影响研究[J].实用药物与临床,2019,22(11):1194-1198.
14、 蒙晓,何素珍,刘亮辉,等.基于医联体的COPD社区医药协作联盟模式探索[J].今日药学,2020,30(3):197-200. 蒙晓,何素珍,刘亮辉,等.基于医联体的COPD社区医药协作联盟模式探索[J].今日药学,2020,30(3):197-200.
15、 高弘杨.药师进社区,让社会药房的价值重新定位[J].中国药店,2020(9):21-22. 高弘杨.药师进社区,让社会药房的价值重新定位[J].中国药店,2020(9):21-22.
16、 周芳,贾暖,王念吾,等.药师对居家慢病患者开展药学服务实践探讨[J].中国合理用药探索,2020,17(11):9-12. 周芳,贾暖,王念吾,等.药师对居家慢病患者开展药学服务实践探讨[J].中国合理用药探索,2020,17(11):9-12.
17、 曹馨,马志敏,程萍,等.家庭药师对社区糖尿病患者开展药学监护的实践和探索[J].中国现代医药杂志,2020,22(11):92-94. 曹馨,马志敏,程萍,等.家庭药师对社区糖尿病患者开展药学监护的实践和探索[J].中国现代医药杂志,2020,22(11):92-94.
18、 盖迪,赵雯,徐慧,等.妊娠期糖尿病患者的治疗现状调查[J].临床药物治疗杂志,2021,19(3):71-76. 盖迪,赵雯,徐慧,等.妊娠期糖尿病患者的治疗现状调查[J].临床药物治疗杂志,2021,19(3):71-76.
1、李星.腹膜透析患者药物相关问题分析及药物治疗管理实施效果评价[D].大理大学,2023.DOI:10.27811/d.cnki.gdixy.2023.000254. 李星.腹膜透析患者药物相关问题分析及药物治疗管理实施效果评价[D].大理大学,2023.DOI:10.27811/d.cnki.gdixy.2023.000254.
2、伍清芳,刘可欣,杨诗雯,等.基于CiteSpace的国内外家庭药师实践进展[J].医药导报,2024,43(01):68-77. 伍清芳,刘可欣,杨诗雯,等.基于CiteSpace的国内外家庭药师实践进展[J].医药导报,2024,43(01):68-77.
3、沈杰,高宁舟,郑松柏,等.老年人多重用药评估与管理中国专家共识(2024)[J].中华老年医学杂志,2024,43(03):269-278. 沈杰,高宁舟,郑松柏,等.老年人多重用药评估与管理中国专家共识(2024)[J].中华老年医学杂志,2024,43(03):269-278.
4、曹肖龙,瞿建刚.静配中心医嘱审核药师参与临床路径管理对用药合理性的影响研究[J].延边大学医学学报,2025,48(03):88-90.DOI:10.16068/j.1000-1824.2025.03.025. 曹肖龙,瞿建刚.静配中心医嘱审核药师参与临床路径管理对用药合理性的影响研究[J].延边大学医学学报,2025,48(03):88-90.DOI:10.16068/j.1000-1824.2025.03.025.
5、吴桂文,何杏仪,吴端仪,等.药师参与智慧药学平台维护管理的成效分析[J].现代医院,2025,25(06):951-953. 吴桂文,何杏仪,吴端仪,等.药师参与智慧药学平台维护管理的成效分析[J].现代医院,2025,25(06):951-953.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录